Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rational Emotive Behavior Therapy01:24

Rational Emotive Behavior Therapy

324
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
324
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

780
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
780
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

590
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
590
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta-Blocker Discontinuation in Acute Heart Failure: A Systematic Review and Meta-Analysis.

JACC. Advances·2026
Same author

Beta-Blocker Discontinuation After Myocardial Infarction: A Systematic Review and Meta-Analysis.

JACC. Advances·2026
Same author

Transposition of the right renal artery to gastroduodenal artery for management of acute, symptomatic renovascular hypertension.

Journal of vascular surgery cases and innovative techniques·2026
Same author

How Are Deprescribing Clinical Practice Guidelines Disseminated and Implemented? A Cross-Sectional Study of International Organisational Stakeholders.

Basic & clinical pharmacology & toxicology·2026
Same author

Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning-based cohort study.

BMJ open·2026
Same author

Sustainability pharmacy assistants in large urban hospital system.

The International journal of pharmacy practice·2026
Same journal

Prevalence of Comorbid Postpartum Depression and Anxiety in Birthing Parents Seeking Treatment for Postpartum Depression: Prévalence de la présence comorbide de la dépression et de l'anxiété post-partum chez les parents ayant accouché qui ont consulté en raison de la dépression post-partum.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same journal

Healthcare Pattern of Use Before and After Initiating a Long-Acting Antipsychotic Among a Cohort of 6221 Patients With a History of Psychosis.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same journal

Understanding Illicit Prescription Painkiller Use: A Multivariable Exploration of Mental Health and Other Predictors Among Canadian University Students: Comprendre la consommation illicite d'analgésiques sur ordonnance : une analyse multivariée de la santé mentale et d'autres facteurs prédictifs chez les étudiants universitaires canadiens.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same journal

Update on ADHD genetics: A practitioner's perspective: Mise à jour sur la génétique du TDAH : le point de vue d'un praticien.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same journal

A Chatbot for the Management of Bipolar Disorder: Using Retrieval-Augmented Generation With an Open-Weight Large Language Model to Answer Clinical Questions Based on the CANMAT and ISBD 2018 Guidelines for Bipolar Disorder: Un dialogueur pour la prise en charge du trouble bipolaire : utiliser la génération augmentée par récupération avec un grand modèle de langage (GML) à poids ouverts pour répondre aux questions cliniques fondées sur les lignes directrices de 2018 de CANMAT et de l'ISBD relatives au trouble bipolaire.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same journal

SSTICS, SACCS, and SASCCS: Clarifying Nomenclature and Robustness in Meta-Analytic Research.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

39.5K

Rising Escitalopram Use in British Columbia: Is it Rational and Evidence-Informed?

Dionzie Ong1, Simroop Ladhar1, Thomas Perry2

  • 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|December 26, 2025
PubMed
Summary
This summary is machine-generated.

Escitalopram offers no significant efficacy or safety benefits over citalopram for major depression, despite its higher cost. This comparison of antidepressants found no meaningful differences in effectiveness or side effects.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Psychiatry

Background:

  • Citalopram and escitalopram are commonly prescribed antidepressants.
Keywords:
citalopramdepressionenantiomersescitalopramselective serotonin reuptake inhibitors

More Related Videos

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.6K
Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
14:55

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI

Published on: April 18, 2011

14.2K

Related Experiment Videos

Last Updated: Jan 7, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

39.5K
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.6K
Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
14:55

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI

Published on: April 18, 2011

14.2K
  • Escitalopram is marketed as superior to citalopram in efficacy, safety, and speed of action.
  • Escitalopram is approximately twice as expensive as citalopram in Canada.